Jesse Weidow

Jesse Weidow serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical research responses to emerging infectious and immunologic threats. Responsible for managing complex acquisition strategies, Weidow oversees contracts for critical research infrastructure, high-containment laboratory services, and advanced computing systems essential to biosafety and biocontainment operations. Their work directly enables NIAID’s ability to deploy rapid diagnostic tools, therapeutic countermeasures, and scalable data platforms in response to public health emergencies, aligning procurement activities with national biodefense priorities. Weidow maintains consistent contracting relationships with Quality Biological, Inc., a leading provider of biological reference materials and biosafety-grade reagents, and GENOMIC LABS LTD, a specialized provider of genomic sequencing and bioinformatics services. These partnerships reflect a focus on high-integrity, mission-critical suppliers with proven expertise in bioscience compliance and laboratory-grade support. The working relationship pattern emphasizes technical rigor, regulatory adherence, and supply chain reliability over volume-based procurement, prioritizing vendors capable of meeting stringent biosafety and data integrity standards. Weidow’s procurement portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability and mission readiness over socioeconomic categorization, indicating a procurement approach grounded in performance requirements rather than socioeconomic targeting. While small business participation is not formally prioritized, vendor selection remains driven by domain expertise and operational readiness. The primary NAICS focus areas are 518210 for computing infrastructure and data processing services, and 332999 for specialized fabricated metal products used in high-containment laboratory systems. These reflect a technical domain expertise in secure data management, high-throughput genomic analysis, and engineered containment environments—core capabilities underpinning NIAID’s response infrastructure for biosafety level 3 and 4 research operations.